Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Lancet. Oncology|October 3, 2012
Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapyAlexander Drilon, Natasha Rekhtman, Marc Ladanyi, et al.
ACG Case Reports Journal|February 23, 2026
Balancing Act: Lessons From Comanaging Patients With Inflammatory Bowel Disease and HIV/AIDSErick Cruz Grave, Paul Paik, John Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Selective regulation of IL-10 signaling and function by zymosanZhimei Du, Erin Kelly, Ingrid Mecklenbräuker, et al.
Hepatology Communications|February 1, 2023
Evaluating sleep in covert encephalopathy with wearable technology: results from the WATCHES studyAdam Buckholz, Lindsay Clarke, Paul Paik, et al.
Nature Immunology|October 7, 2004
Amplification of IFN-alpha-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptorsIoannis Tassiulas, Xiaoyu Hu, Hao Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2018
Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonistGeorge R Uhl, Maria J Martinez, Paul Paik, et al.
Histopathology|September 21, 2022
Non-small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumoursOmid Savari, Christopher Febres-Aldana, Jason C Chang, et al.
JCO Precision Oncology|August 11, 2022
SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor InhibitorsHiroki Sato, Daisuke Kubota, Huan Qiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2016
TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's diseaseXiaobei Zhao, Xu-Qiao Chen, Eugene Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitorsHelena A Yu, Camelia S Sima, James Huang, et al.
Pageof 2